Kabiven (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

The amino acids in Kabiven are directly available in the bloodstream, serving as building blocks for protein synthesis and supporting nitrogen balance. They also participate in metabolic pathways like gluconeogenesis and neurotransmitter production, helping maintain cellular function when enteral feeding is not possible.

The dose of Kabiven is individualized. A qualified prescriber determines the volume and rate based on the patient’s weight, clinical condition, and nutritional requirements, following institutional protocols for total parenteral nutrition.

The safety of Kabiven in pregnancy or lactation has not been fully established. Use is generally reserved for situations where the benefits outweigh potential risks, and it should be prescribed by a specialist familiar with maternal‑fetal considerations.

To order Kabiven, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Kabiven offers a comprehensive blend of essential and non‑essential amino acids in a single sterile solution, matching the amino acid profile recommended for adult total parenteral nutrition. Compared with products that provide separate amino acid modules, Kabiven simplifies preparation and reduces the risk of mixing errors, while delivering comparable nutritional support.

Kabiven should be stored at 2‑8 °C in a refrigerator, protected from light. Do not freeze or shake the vial. Before use, inspect the solution for particulate matter or discoloration and allow it to reach room temperature if required by the administration protocol.

Kabiven is administered intravenously as a sterile solution for injection. It is typically infused through a central venous catheter or a peripheral line, using an infusion pump to control the rate according to the prescribed total parenteral nutrition regimen.

Serious risks include anaphylactic reactions, metabolic acidosis, and severe electrolyte disturbances such as hypernatremia. Clinicians should monitor patients closely for signs of allergic response, acid‑base balance, and electrolyte levels throughout the infusion.

Kabiven is contraindicated in patients with known hypersensitivity to any of its amino acid components, those with uncontrolled severe electrolyte abnormalities, or individuals for whom total parenteral nutrition is not indicated. Clinical judgment should guide use in patients with severe hepatic or renal impairment.